GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinling Pharmaceutical Co Ltd (SZSE:000919) » Definitions » Shiller PE Ratio

Jinling Pharmaceutical Co (SZSE:000919) Shiller PE Ratio : 18.67 (As of Jun. 24, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Jinling Pharmaceutical Co Shiller PE Ratio?

As of today (2024-06-24), Jinling Pharmaceutical Co's current share price is ¥6.16. Jinling Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.33. Jinling Pharmaceutical Co's Shiller PE Ratio for today is 18.67.

The historical rank and industry rank for Jinling Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SZSE:000919' s Shiller PE Ratio Range Over the Past 10 Years
Min: 15.27   Med: 22.53   Max: 69.02
Current: 18.67

During the past years, Jinling Pharmaceutical Co's highest Shiller PE Ratio was 69.02. The lowest was 15.27. And the median was 22.53.

SZSE:000919's Shiller PE Ratio is ranked better than
62.43% of 535 companies
in the Drug Manufacturers industry
Industry Median: 23.79 vs SZSE:000919: 18.67

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jinling Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.085. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.33 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Jinling Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Jinling Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinling Pharmaceutical Co Shiller PE Ratio Chart

Jinling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.42 21.26 21.81 22.66 24.22

Jinling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.55 23.20 24.66 24.22 21.00

Competitive Comparison of Jinling Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Jinling Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jinling Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jinling Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jinling Pharmaceutical Co's Shiller PE Ratio falls into.



Jinling Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jinling Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=6.16/0.33
=18.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jinling Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Jinling Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.085/115.2271*115.2271
=0.085

Current CPI (Mar. 2024) = 115.2271.

Jinling Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.136 98.200 0.160
201409 0.104 98.900 0.121
201412 0.070 99.000 0.081
201503 0.114 99.900 0.131
201506 0.116 99.500 0.134
201509 0.091 100.500 0.104
201512 0.092 100.600 0.105
201603 0.095 102.200 0.107
201606 0.123 101.400 0.140
201609 0.087 102.400 0.098
201612 0.053 102.600 0.060
201703 0.085 103.200 0.095
201706 0.114 103.100 0.127
201709 0.084 104.100 0.093
201712 -0.012 104.500 -0.013
201803 0.094 105.300 0.103
201806 0.084 104.900 0.092
201809 0.059 106.600 0.064
201812 0.243 106.500 0.263
201903 0.417 107.700 0.446
201906 0.034 107.700 0.036
201909 0.018 109.800 0.019
201912 -0.181 111.200 -0.188
202003 -0.055 112.300 -0.056
202006 0.103 110.400 0.108
202009 0.106 111.700 0.109
202012 -0.025 111.500 -0.026
202103 0.069 112.662 0.071
202106 0.081 111.769 0.084
202109 0.043 112.215 0.044
202112 0.046 113.108 0.047
202203 0.077 114.335 0.078
202206 0.040 114.558 0.040
202209 0.066 115.339 0.066
202212 0.026 115.116 0.026
202303 0.087 115.116 0.087
202306 0.067 114.558 0.067
202309 0.040 115.339 0.040
202312 0.004 114.781 0.004
202403 0.085 115.227 0.085

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jinling Pharmaceutical Co  (SZSE:000919) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Jinling Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Jinling Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinling Pharmaceutical Co (SZSE:000919) Business Description

Traded in Other Exchanges
N/A
Address
No. 238 Zhongyang Road, Jinling Pharmaceutical Building, Nanjing, Jiangsu, CHN, 210009
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.
Executives
Fan Jin Tian Director
Jia Ming Yi Executives
Li Quan Executives
Chen Sheng Executives
Xu Jun Yang Secretary Dong
Wang Yang Executives
Yin Jian Biao Executives
Li Jian Executives
Liang Yu Tang Directors, executives
Zhang Ning Executives
Li Chun Min Director
Sui Li Cheng Executives
Tang Wei Guo Directors, executives
Wang Suo Jin Executives
Shen Zhi Long Director

Jinling Pharmaceutical Co (SZSE:000919) Headlines

No Headlines